PDL BioPharma, Inc. PDLIV
NASDAQ
Recommendation
Dividend Power Score
Day's Range
Latest Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
--
| 08/31/2020 | 06/30/2020 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -15.99% | |||
| Total Receivables | -- | -2.80% | |||
| Inventory | -- | 19.83% | |||
| Prepaid Expenses | -- | 33.07% | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -13.02% | |||
| Total Current Assets | -- | -10.11% | |||
|
|
|||||
| Total Current Assets | -- | -10.11% | |||
| Net Property, Plant & Equipment | -- | -6.89% | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -2.59% | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -58.15% | |||
| Total Assets | -- | -21.09% | |||
|
|
|||||
| Total Accounts Payable | -- | -32.61% | |||
| Total Accrued Expenses | -- | 25.52% | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | -- | -24.15% | |||
| Total Other Current Liabilities | -- | -24.15% | |||
| Total Current Liabilities | -- | -13.19% | |||
|
|
|||||
| Total Current Liabilities | -- | -13.19% | |||
| Long-Term Debt | -- | 1.54% | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -1.42% | |||
| Total Liabilities | -- | -5.65% | |||
|
|
|||||
| Common Stock & APIC | -- | -5.48% | |||
| Retained Earnings | -- | -21.84% | |||
| Treasury Stock & Other | -- | 4.26% | |||
| Total Common Equity | -- | -24.00% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | -- | -24.00% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -324.55% | |||
| Total Equity | -- | -24.07% | |||
|
|
|||||